Abstract
AbstractAntibiotic resistance has become a critical issue, alarming the healthcare and agriculture sectors worldwide. Thanks to rapid advancements in polymer science, antimicrobial polymers (AMPs) have been developed as a mimic version of host‐defense peptides (a part of natural immune systems of multicellular organisms) to mitigate antibiotic resistance. By exploiting advanced polymerization techniques, polymer structures are easily manipulated in a well‐defined controlled manner, enabling precise and accurate evaluation of the structure–activity relationship. Recent years have witnessed the blossoming of antimicrobial polymer development. This review provides comprehensive insight into antimicrobial polymers from concept to structure design, to biofunction control. Along with the optimization of intrinsic factors, including compositional and topological features, external factors like induced conformation upon exposure to specific targeting pathogens should be considered in AMP design and optimization. Furthermore, the new design approaches of smart response platforms (or bacterial‐induced triggering systems) and targeting specific administration dosage forms for specific pathogens are also discussed as prospective strategies to address the remaining challenge of toxicity while maintaining or even enhancing antimicrobial potency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.